Use of FRAX as a determinant for risk-based osteoporosis screening may decrease unnecessary testing while improving...

Area of Science:

• Gerontology
• Preventive Medicine
• Bone Health

Background:

• Osteoporosis screening guidelines aim to identify individuals at high risk for fractures.
• Different guidelines, such as USPSTF and NOF, have varying criteria for initiating screening.
• Evaluating the impact of these guidelines on screening rates and identification of treatment candidates is crucial for optimizing patient care.

Purpose of the Study:

• To assess the hypothetical impact of guideline-concordant osteoporosis screening on baseline behaviors.
• To determine the relative ability of USPSTF and NOF guidelines to identify osteoporosis treatment candidates in women aged 50-64.

Main Methods:

• Secondary analysis of data from the Fracture Risk Perception Study.
• Inclusion of patients aged 50-75 years who completed bone health questionnaires.
• Hypothetical application of USPSTF (FRAX 9.3% threshold) and NOF (risk-based) screening criteria to women aged 50-64.

Main Results:

• NOF criteria would test 71% of women (102/144) to identify 86% of treatment candidates (12/14).
• USPSTF criteria would test 31% of women (45/144) to identify 79% of treatment candidates (11/14).
• USPSTF criteria significantly reduced unnecessary testing (56% reduction) and improved the odds of identifying treatment candidates (OR 10.35).

Conclusions:

• Systematic FRAX calculation and applying the USPSTF 9.3% fracture risk threshold can decrease unnecessary osteoporosis screening in younger women.
• This approach effectively identifies appropriate candidates for osteoporosis treatment.
• Guideline adherence is key for efficient and effective osteoporosis management.